findmyKOL

Joe Verghese, MD

Enriched profile

Professor and Chair of Neurology, Renaissance School of Medicine at Stony Brook University · Renaissance School of Medicine at Stony Brook University

ORCIDNPI
Region🇺🇸 Lake Grove, NY · Northeast · United StatesSpecialtyNeurologyFocusDementia and Cognitive Impairment Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2023–2024NIH funding2004–2026

Joe Verghese is Professor and Chair of Neurology, Renaissance School of Medicine at Stony Brook University at Renaissance School of Medicine at Stony Brook University. OpenAlex indexes 489 publications with 31,578 citations (h-index 84); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Joe Verghese, M.D., is Professor and Chair of Neurology, Renaissance School of Medicine at Stony Brook University. The public record shows 489 publications with 31,578 citations (h-index 84), centered on Dementia and Cognitive Impairment Research, Balance, Gait, and Falls Prevention, Older Adults Driving Studies. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 2 companies, 18 NIH-funded awards (2004–2026).

  • Most recent indexed publication: 2026 · Neurology
  • Top research focus: Dementia and Cognitive Impairment Research
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Alzheimer's / Dementia4 trialsDementia4 trialsCognitive Dysfunction2 trialsMobility Limitation1 trialNeurocognitive Disorders1 trialCOVID-191 trial

Research focus

OpenAlex concept fingerprint
Dementia and Cognitive Impairment ResearchBalance, Gait, and Falls PreventionOlder Adults Driving StudiesCerebral Palsy and Movement DisordersFrailty in Older Adults

Drugs & molecules

across trials, industry payments and publications
Leqembigeneric · LecanemabClinical trialsIndustry payments1PublicationsNourianzgeneric · IstradefyllineClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Albert Einstein College of MedicineClinical trials6Industry paymentsEisai Inc.Clinical trialsIndustry payments1Kyowa Kirin, Inc.Clinical trialsIndustry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
489publications

Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.

31,578citations

Total citations across indexed works.

84h-index

Hirsch index (OpenAlex). i10-index 260.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
2companies · 2023–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments
18NIH grants · 2004–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

2 companies reported payments to CMS in program years 2023–2024. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Cholinesterase Inhibitor54.5%
    Donepezil Hcl51%Galantamine Er36%Galantamine Hbr13%
    Part D<11 patients
    N-methyl-D-aspartate Receptor Antagonist24.7%
    Memantine Hcl100%
    Part D13 patients
Where care is delivered (Part B), 20230% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 31 Aug 2026

18 NIH research awards on record, funded 20042026 per NIH RePORTER. The latest:

Congress activity

Updated 31 Aug 2026

3 congress contributions (2017–2025) across AACE, ASTRO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 31 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 31 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emmeline Ayers107Helena M. Blumen82Richard B. Lipton78

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/joe-verghese-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Joe-Verghese-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/stonybrooku/videos/endowed-chair-of-neurology-joe-verghese-md-ms-frcpi-leads-research-on-aging-cogn/1586966079295649

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • LinkedIn

    linkedin.com/posts/stonybrookuniversity_endowed-chair-of-neurology-joe-verghese-activity-7419412987943239681-68v9

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Other

    irepod.com/podcast/brain-body-things/how-movement-relates-to-dementia-with-dr-joe-vergh

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →irepod.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
6 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
2 more awards behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.